Company intelligence / Profile preview
Faran Shimi
Tehran, Iranfaranshimi.com ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
Faran Shimi produces both active pharmaceutical ingredients and finished dosage forms, including opioid alkaloids and several generic and specialized medicines, and supplies Iran and the broader Middle Eastern market with commercialized products covering pain, diabetes, neurology, and other major indications.
- Therapeutic areas
- EndocrinologyNephrologyPsychiatryInfectious DiseasesGastroenterologyPulmonologyCardiovascularOtherNeurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Faran Shimi.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Faran Shimi.